INTERNATIONAL PATENT: PHARMAESSENTIA CORPORATION, LIN, KO-CHUNG FILES APPLICATION FOR "COMPOSITION AND METHOD OF TREATING HUMAN T CELL LYMPHOTROPIC VIRUS ASSOCIATED DISEASE"

GENEVA, April 29 -- PHARMAESSENTIA CORPORATION (13f, No. 3 Park StreetNangang DistrictTaipei, 115), LIN, Ko-Chung (253 Lincoln StreetLexington, MA 02421) filed a patent application (PCT/US2025/050340) for "COMPOSITION AND METHOD OF TREATING HUMAN T CELL LYMPHOTROPIC VIRUS ASSOCIATED DISEASE" on Oct 09, 2025. With publication no. WO/2026/084962, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SATO, Toshiaki (1-3-13 Motoakasaka, Minato-kuAkasaka Center Building 12FTokyo, 107-0051)

Abstract: Disclosed herein is a compositio...